Yi‐Jou Tai

786 citations
35 papers · 561 indexed · h-index 11
Topics
Endometrial and Cervical Cancer Treatments (12 papers)Ovarian cancer diagnosis and treatment (9 papers)Cervical Cancer and HPV Research (6 papers)
Partner nations
TaiwanSouth KoreaIreland

In The Last Decade

Yi‐Jou Tai

31 papers receiving 548 citations

Peers

Yi‐Jou Tai
Comparison fields: 5 of 80
  • Oncology 260
  • Immunology 210
  • Molecular Biology 133
  • Cancer Research 65
  • Reproductive Medicine 62
Replace Kawaljit Kaur with:
Kawaljit Kaur United States
S. Staibano Italy
Brett V. Johnson Australia
Nicholas Larocque United States
Véronique Catros France
Biancamaria Ricci Italy
Alexander Marmé Germany
Jayeeta Giri United States
Vivien Grant United Kingdom
Kurosh Rahimi Canada
Yi‐Jou Tai relative to Kawaljit Kaur United States Kawaljit Kaur's profile →
Citations per field
00.5×1.5×2.5×
Kawaljit Kaur · 1×
Citations per year

Countries citing papers authored by Yi‐Jou Tai

Since Specialization
Citations

This map shows the geographic impact of Yi‐Jou Tai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi‐Jou Tai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi‐Jou Tai more than expected).

Fields of papers citing papers by Yi‐Jou Tai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi‐Jou Tai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi‐Jou Tai. The network helps show where Yi‐Jou Tai may publish in the future.

Co-authorship network of co-authors of Yi‐Jou Tai

This figure shows the co-authorship network connecting the top 25 collaborators of Yi‐Jou Tai. A scholar is included among the top collaborators of Yi‐Jou Tai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi‐Jou Tai. Yi‐Jou Tai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 0
4 2
5 4
6 1
7 3
8 12
9 2
10
Overexpression of transmembrane protein 102 implicates poor prognosis and chemoresistance in epithelial ovarian carcinoma patients.
2
11 4
12 19
13 13
14 16
15 11
16 11
17 225
18 4
19 0
20 55

About Yi‐Jou Tai

Yi‐Jou Tai is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Biological Psychiatry, having authored 35 papers that have together received 561 indexed citations. Recurring topics across this work include Endometrial and Cervical Cancer Treatments (12 papers), Ovarian cancer diagnosis and treatment (9 papers) and Cervical Cancer and HPV Research (6 papers). The work is most often cited by research in Immunology (210 citations), Oncology (260 citations) and Developmental Neuroscience (33 citations). Yi‐Jou Tai has collaborated with scholars based in Taiwan, South Korea and Ireland. Frequent co-authors include Ying‐Cheng Chiang, Wen‐Fang Cheng, Qi Zhang, Yu‐Li Chen, Chi‐An Chen, Heng‐Cheng Hsu, Han-Wei Lin, Chi-Fang Chang, Wei‐Zen Sun and Chun‐Pin Chiang. Their work appears in journals such as PLoS ONE, The Journal of Physical Chemistry B and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026